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Infectious Disease Epidemiology Report 
Hepatitis A in Maine, 2012   
 
 
 
 
 
Background 
Hepatitis A is a liver disease caused by hepatitis A 
virus (HAV).  HAV is spread from person to person 
by the fecal-oral route. Poor hand washing by 
infected persons increases the risk of transmission.  
The virus spreads more easily in areas where 
sanitary conditions and personal hygiene practices 
are poor. Most infections result from exposure 
during international travel or contact with a 
household member or sex partner who has 
hepatitis A. Casual contact, as in the office or 
school setting, does not typically spread the virus.  
 
Signs and symptoms of acute HAV infection include 
tiredness, loss of appetite, nausea, abdominal 
discomfort, dark urine, clay-colored stool, jaundice 
and elevated liver function tests. Acute HAV 
infection is classified by a discrete onset of 
symptoms, elevated liver enzymes or jaundice, and 
positive serology. Symptoms appear within 15 to 50 
days of infection with the virus, although children 
are less likely to have symptoms. There is no 
chronic form of hepatitis A and infection provides 
lifelong immunity. There is a vaccine for hepatitis A. 
 
Methods 
Acute HAV infections in Maine are reportable 
immediately upon recognition or strong suspicion of 
disease. Reported cases are investigated by Maine 
CDC to determine the exposure, identify close 
contacts, and make recommendations for post-
exposure prophylaxis and prevention.  
 
Results 
In 2012, nine cases of acute hepatitis A were 
reported in Maine compared to six cases in the 
previous year. The rate of acute HAV infection in 
Maine was 0.7 cases per 100,000 persons in 2012 
(Figure 1). 
 
The majority of the cases (78%) were female in 
2012 (Figure 2).   
 
 
 
 
 
 
 
Figure 1. Rate of hepatitis A, Maine 
and U.S., 2008-2012
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Figure 2. Count of hepatitis A, Maine 
2008-2012 (N=41)
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Risk factor information was collected for all nine 
cases in 2012. Three cases (33%) reported travel 
history during the exposure period. One case 
identified as a man who has sex with men (MSM). 
No risk factor was reported for the remaining five 
(56%) cases.  
In 2012, hepatitis A cases were reported from five 
Maine counties. Five cases (56%) were reported 
from Cumberland county and one case each was 
reported from Androscoggin, Kennebec, Oxford, 
and York counties (Figure 3). 
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Prevention and Control 
Prevention measures for HAV infection include the 
following:   
• Consider vaccination for all children and 
persons at increased risk for HAV infection, 
including travelers, MSM, drug users, 
persons with occupational risk for infection, 
and persons with clotting factor disorders 
• Practice good hand washing, especially 
before handling or eating food, after toilet 
use and after changing diapers 
• Dispose of feces in a sanitary manner in 
daycare or residential settings 
• Avoid sexual practices that may allow fecal-
oral transmission 
• When traveling, do not drink tap water or 
use ice and avoid eating uncooked foods in 
developing countries where the water may 
not be safe and sanitation is poor 
 
 
 
Hepatitis A is vaccine-preventable in persons aged 
one and older. The vaccine is administered in a 2-
dose schedule, six months apart. A combined 
hepatitis A and hepatitis B (Twinrix) vaccine is also 
available for adults age 18 and older.  Hepatitis A 
vaccine is recommended routinely for children and 
for household members and other close personal 
contacts of adopted children newly arriving from 
countries where HAV infection is endemic.  
 
Infection with HAV can be avoided after exposure 
to a confirmed case with timely administration of 
hepatitis A vaccine or immune globulin. This is 
called post-exposure prophylaxis and is effective if 
given within two weeks of exposure.  
• For healthy persons aged 12 months-40 
years, single-antigen hepatitis A vaccine at 
the age-appropriate dose is preferred.  
• For persons aged >40 years, IG is 
preferred; vaccine can be used if IG cannot 
be obtained.  
• IG should be used for children aged <12 
months, immunocompromised persons, 
persons who have had chronic liver disease 
diagnosed, and persons for whom vaccine 
is contraindicated. 
 
Due to the likelihood for false positive results when 
diagnostic testing for hepatitis A virus is performed 
on asymptomatic persons, CDC recommends that 
healthcare providers limit use of IgM anti-HAV 
testing to persons with evidence of clinical hepatitis 
or to those who have had recent exposure to a 
person with an acute HAV infection. Providers 
should also not use IgM anti-HAV as a screening 
tool for asymptomatic persons or as part of testing 
panels for the workup of non-acute liver function 
abnormalities. 
 
Acute hepatitis A cases are required to be reported 
immediately to Maine CDC at 1-800-821-5821. 
Information about hepatitis A is available online at 
www.maine.gov/idepi and www.cdc.gov.    
 
 
Figure 3. Hepatitis A cases by county, 2012 
 
 
